EMPORITY Trademark

Trademark Overview

On Thursday, February 4, 2016, a trademark application was filed for EMPORITY with the United States Patent and Trademark Office. The USPTO has given the EMPORITY trademark a serial number of 86897464. The federal status of this trademark filing is REGISTERED as of Tuesday, January 26, 2021. This trademark is owned by Sun Pharma Global FZE. The EMPORITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders; Pharmaceutical preparations for the treatment of cancer
empority

General Information

Serial Number86897464
Word MarkEMPORITY
Filing DateThursday, February 4, 2016
Status700 - REGISTERED
Status DateTuesday, January 26, 2021
Registration Number6253893
Registration DateTuesday, January 26, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system; Pharmaceutical preparations for the treatment of immune system related diseases and disorders and immunologically mediated inflammatory disorders; Pharmaceutical preparations for the treatment of cancer
Translation of Words in MarkThe wording "EMPORITY" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 9, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSUN PHARMACEUTICAL INDUSTRIES LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressVADODARA, GUJARAT 390012
IN
Party NameSun Pharma Global FZE
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDubai
AE
Party NameSun Pharma Global FZE
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDubai
AE

Trademark Events

Event DateEvent Description
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, January 26, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2020PUBLISHED FOR OPPOSITION
Wednesday, October 21, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 6, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 6, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 30, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, April 1, 2020NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, April 1, 2020INQUIRY TO SUSPENSION E-MAILED
Wednesday, April 1, 2020SUSPENSION INQUIRY WRITTEN
Monday, March 30, 2020SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Monday, September 9, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 9, 2019LETTER OF SUSPENSION E-MAILED
Monday, September 9, 2019SUSPENSION LETTER WRITTEN
Monday, September 9, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 9, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 5, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, March 6, 2019NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, March 6, 2019INQUIRY TO SUSPENSION E-MAILED
Wednesday, March 6, 2019SUSPENSION INQUIRY WRITTEN
Tuesday, March 5, 2019SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Thursday, February 28, 2019ASSIGNED TO LIE
Friday, August 10, 2018REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, August 10, 2018ASSIGNED TO LIE
Wednesday, January 31, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 31, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, January 31, 2018SUSPENSION LETTER WRITTEN
Friday, January 26, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 26, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 24, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, January 24, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 27, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 27, 2017INQUIRY TO SUSPENSION E-MAILED
Thursday, July 27, 2017SUSPENSION INQUIRY WRITTEN
Wednesday, July 26, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Tuesday, January 17, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, January 17, 2017LETTER OF SUSPENSION E-MAILED
Tuesday, January 17, 2017SUSPENSION LETTER WRITTEN
Tuesday, January 17, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 17, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 9, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 2, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, December 2, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, December 2, 2016SUSPENSION INQUIRY WRITTEN
Tuesday, November 29, 2016SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Friday, November 18, 2016ASSIGNED TO LIE
Monday, May 16, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, May 16, 2016LETTER OF SUSPENSION E-MAILED
Monday, May 16, 2016SUSPENSION LETTER WRITTEN
Thursday, May 12, 2016ASSIGNED TO EXAMINER
Wednesday, March 23, 2016TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, March 23, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Tuesday, February 9, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 8, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

empority pharmaceutical disorders treatment preparations system diseases mediated inflammatory cancer immunologically